Eur Rev Med Pharmacol Sci 2021; 25 (18): 5578-5578

DOI: 10.26355/eurrev_202109_26774

Author Correction: LncRNA HOTAIRM1 inhibits the progression of hepatocellular carcinoma by inhibiting the Wnt signaling pathway

Y. Zhang, L. Mi, Y. Xuan, C. Gao, Y.-H. Wang, H.-X. Ming, J. Liu

Department of Hepatobiliary Surgery, Provincial Hospital Affiliated to Shandong University, Jinan, China


Correction to: European Review for Medical and Pharmacological Sciences 2018; 22 (15): 4861-4868–DOI: 10.26355/eurrev_201808_15622–PMID: 30070317, published online 15 August 2018.

After publication, the authors found some mistakes in the article.

There are amendments to this paper. The Publisher apologizes for any inconvenience this may cause.

LncRNA HOTAIRM1 inhibits the progression of hepatocellular carcinoma by inhibiting the Wnt signaling pathway

Free PDF Download

To cite this article

Y. Zhang, L. Mi, Y. Xuan, C. Gao, Y.-H. Wang, H.-X. Ming, J. Liu
Author Correction: LncRNA HOTAIRM1 inhibits the progression of hepatocellular carcinoma by inhibiting the Wnt signaling pathway

Eur Rev Med Pharmacol Sci
Year: 2021
Vol. 25 - N. 18
Pages: 5578-5578
DOI: 10.26355/eurrev_202109_26774